The potential of magnesium alloy use in orthopaedic surgery

Current Orthopaedic Practice

Volumn 23, Issue 2, 2012, Pages 146-150

  Barfield, William R ^a,b   Colbath, Gregory ^a   DesJardins, John D ^c   An, Yuehuei H ^a   Hartsock, Langdon A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b School of Business and Economics   (United States)

^c South   (United States)

Author keywords

Alloys; Implants; Magnesium; Orthopaedic surgery

Indexed keywords

ALLOY; ALUMINUM; APATITE; CHROMIUM; COBALT; HYDROGEN; HYDROXYAPATITE; MAGNESIUM; METAL ION; STEEL; TITANIUM;

BIOCOMPATIBILITY; BIODEGRADABILITY; BONE METABOLISM; BONE STRESS; CELL PROLIFERATION; CERAMICS; CORROSION; DENSITY; ELASTICITY; FRACTURE IMMOBILIZATION; HEALTH CARE COST; HUMAN; IMMUNE RESPONSE; IMPLANT; IN VIVO STUDY; INFECTION; INFLAMMATION; INTRAMEDULLARY NAILING; MOLECULAR STABILITY; MORBIDITY; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLASTOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; RIGIDITY; SURGICAL RISK;

EID: 84858433071     PISSN: 19407041     EISSN: 19417551     Source Type: Journal    
DOI: 10.1097/BCO.0b013e31824a553b     Document Type: Review

References (44)

1. Lambotte A. L'utilisation of magnesium comme materiel perdu dans l'osteosynthese. Bull Mem Soc Nat Chir. 1932; 28:1325-1334.
2. McBride ED. Absorbable metal in bone surgery. J American Med Assoc. 1938; 111:2464-2467.
3. Troitskii VV, Tsitrin DN. The resorbing metallic alloy "Osteosinthezit" as material for fastening broken bone. Khirurgiia. 1944; 8:41-44.
4. Levesque J, Dube D, Fiset M, et al. Investigation of corrosion behavior of magnesium alloy AM60B-F under pseudo-physiological conditions. Mater Sci Forum. 2003; 426:521-526.
5. McCord CP. Chemical gas gangrene from metallic magnesium. Ind Med. 1942; 11:71-79.
6. Xin Y, Liu C, Zhang X, et al. Corrosion behavior of biomedical AZ 91 magnesium alloy in simulated body fluids. J Mater Res. 2007; 22:2004-2011. (Pubitemid 47098583)
7. Blunt JW, Hudack SS, Murray CR. Metals and Plastics in Orthopaedic Surgery and General Surgery. New York, NY: Clinical Congress, American College of Surgeons; 1952.
8. Smith-Peterson MN. Arthroplasty of the hip. A new method. J Bone Joint Surg. 1939; 21-A:269-288.
9. Charnley J. Arthroplasty of the hip: A new operation. Lancet. 1961; 1:1129-1132.
10. Pulco DA, Huh WW. Acute toxicity of metal ions in cultures of osteogenic cells derived from bone marrow stromal cells. J Appl Biomater. 1995; 6:109-116.
11. Nagels J, Stokdijk M, Rozing PM. Stress shielding and bone resorption in shoulder arthroplasty. J Shoulder Elbow Surg. 2003; 12:35-39. (Pubitemid 37443368)
12. Witte F, Kaese V, Haferkamp H, et al. In vivo of four magnesium alloys and the associated bone response. Biomaterials. 2005; 26:3557-3563. (Pubitemid 40038150)
13. Liu CC, Yeh JK, Aloia JF. Magnesium directly stimulates osteoblast proliferation. J Bone Miner Res. 1988; 3:S104.
14. Kim SR, Lee JH, Kim YT, et al. Synthesis of Si, Mg, substituted hydroxyapatities and their sintering behaviors. Biomaterials. 2003; 24:1389-1398. (Pubitemid 36074883)
15. Zhang S, Zhang X, Zhao C, et al. Research of Mg-Zn alloy as a degradable biomaterial. Acta Biomater. 2010; 6:626-640.
16. Witte F, Ulrich H, Rudert M. Willbold. Biodegradable magnesium scaffolds: Part I: Appropriate inflammatory response. J Biomed Mater Res A. 2007; 81:748-756. (Pubitemid 46786907)
17. Xu L, Yu G, Zhang E, et al. In vivo corrosion behavior of Mg-Mn- Zn alloy for bone implant application. J Biomed Mater Res A. 2007; 83:703-711. (Pubitemid 350086297)
18. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Res. 1997; 28:5-24. (Pubitemid 27497671)
19. Shikinami Y, Okuno M. Bioresorable devices made of forged composites of hydroxyapatite (HA) particles and poly L- lactide (PLLA). Part 1: Basic characteristics. Biomaterials. 1999; 20:759-877.
20. Pourbaix M. Atlas of Electrochemical Equilbria in Acqueous Solutions. 2nd English ed Houston: National Association of Corrosion Engineers; 1974.
21. Witte F, Fischer J, Nellesen J, et al. In vitro and in vivo corrosion measurements of magnesium alloys. Biomaterials. 2006; 27:1013-1018. (Pubitemid 41566693)
22. Leontis TE, Rhines FN. Rates of high temperature oxidation of magnesium and magnesium alloys. Trans AIME. 1946; 166: 265-294.
23. Witte F, Kaese V, Haferkamp H, et al. In vivo of four magnesium alloys and the associated bone response. Biomaterials. 2005; 26:3557-3563. (Pubitemid 40038150)
24. Maker GL, Kruger J. Corrosion of magnesium. Int Mater Rev. 1993; 38:138-153. (Pubitemid 23680521)
25. Tapiero H, Tew KD. Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed & Pharm. 2003; 57:399-411. (Pubitemid 37498214)
26. Mordike BL, Lukac P. Physical metallurgy. In: Friedrich HE, Mordike BL, eds. Magnesium Technology-metallurgy, Design Data, Applications. Berlin: Springer; 2006:226-227.
27. ClyneTW. Comprehensive Composite Materials. Oxford: Pergamon; 2000.
28. Foltz JV, Blackmon CM. Metal matrix composites. Adv Mater Processes. 1998; 154:19-23.
29. Emley EF. Principles of Magnesium Technology. Oxford: Pergamon Press; 1966.
30. Fulmer MT, Ison IC, Hankermayer CR, et al. Measurements of the solubilities and dissolution rates of several hydroxyapatities. Biomaterials. 2002; 23:751-755. (Pubitemid 33108950)
31. Witte F, Feyerabend F, Petre P, et al. Biodegradable magnesiumhydroxyapatite metal matrix composites. Biomaterials. 2007; 28:2163-2174. (Pubitemid 46216450)
32. Zreiqat H, Valenzuela SM, Nissan BB, et al. The effect of surface chemistry modification of titanium alloy on signaling pathways in human osteoblasts. Biomaterials. 2005; 26:7579-7586. (Pubitemid 41199784)
33. Witte F, Ulrich H, Palm C, et al. Biodegradable magnesium scaffolds. Part II: Peri-implant bone remodeling. J Biomed Mater Res A. 2007; 81:757-765. (Pubitemid 46786908)
34. DeGarmo PE. Materials and Processes in Manufacturing. 5th ed New York: Collin Macmillan; 1979.
35. Vormann J. Magnesium:nutrition and metabolism. Mol Aspects Med. 2003; 24:27-37.
36. Water, Electrolyte Mineral and Acid/Base Metabolism Section 2 Endocrine & Metabolic Disorders. In: Beers MH, Porter RS, Jones TV, eds. Merk Manual of Diagnosis and Therapy, 18th ed. New York, NY: McGraw-Hill, 2006: 155-164.
37. El-Rahman SSA. Neuropathology of aluminum toxicity in rats (glutamate and GABA impairment). Pharmacol Res. 2003; 47:189-193.
38. Serre CM, Papillard M, Chavassieux P, et al. Influence of magnesium substitution on a collagen-apatite biomaterial on the production of a calcifying matrix by human osteoblasts. J Biomed Mater Res. 1998; 42:626-633. (Pubitemid 28503769)
39. Li Z, Gu X, Lou S, et al. The development of binary Mg-Ca alloys for use as biodegradable materials within bone. Biomaterials. 2008; 29:1329-1344.
40. Revell PA, Damien E, Zhang XS, et al. The effect of magnesium ions on bone bonding to hydroxyapatite. Key Eng Mater. 2004; 254-256:447-450.
41. Williams D. New interests in magnesium. Magnesium alloys used for implantable devices. Medical Device Tech. 2006; 17:9.
42. Seal CK, Vince K, Hodgson MA. Biodegradable surgical implants based on magnesium alloys- a review of current research. Materials Sci and Engin. 2009; 4:1-4.
43. Denkena B, Witte F, Podolsky C, et al. Degradable implants made of magnesium alloys. Proc. Of 5th Euspen International Conference - Montpellier, France; May 2005.
44. Thomopoulos S, Zampiakis E, Das R, et al. Use of a magnesiumbased bone adhesive for flexor tendon-to-bone healing. J Hand Surg. 2009; 34:1066-1073.